Free Trial

Viking Therapeutics (VKTX) SEC Filings & 10K Form

Viking Therapeutics logo
$30.19 +2.68 (+9.74%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$30.35 +0.16 (+0.52%)
As of 07/8/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Viking Therapeutics SEC Filings

DateFilerForm TypeView
07/03/2025
2:30 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
2:31 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
2:31 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/03/2025
12:01 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025
12:05 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/03/2025
12:07 PM
Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
05/27/2025
4:20 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/12/2025
9:43 AM
FMR LLC (Filed by)
Viking Therapeutics (Subject)
Form SCHEDULE 13G/A
04/24/2025
3:37 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/23/2025
4:25 PM
Viking Therapeutics (Filer)
Form DEFR14A
04/23/2025
4:26 PM
Viking Therapeutics (Filer)
Form DEFA14A
04/23/2025
3:01 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2025
9:00 AM
BlackRock, Inc. (Filed by)
Viking Therapeutics (Subject)
Form SCHEDULE 13G/A
04/14/2025
6:26 PM
FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2025
6:05 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4/A
04/08/2025
4:23 PM
Viking Therapeutics (Filer)
Form DEFA14A
04/08/2025
4:25 PM
Viking Therapeutics (Filer)
Form ARS
04/02/2025
5:29 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/11/2025
6:05 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2025
3:32 PM
Viking Therapeutics (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
01/06/2025
7:15 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:16 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:11 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:12 PM
FOEHR MATTHEW W (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:13 PM
Rowland Charles A Jr (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:13 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:14 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
7:14 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/06/2025
4:32 PM
Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:25 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/06/2025
4:16 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
5:22 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/08/2024
5:13 PM
MACARTNEY LAWSON (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/04/2024
12:54 PM
VANGUARD GROUP INC (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
11/04/2024
5:31 AM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2024
8:48 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2024
3:37 PM
Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/25/2024
6:27 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
6:28 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/25/2024
3:10 PM
Rouan Sarah Kathryn (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
10/23/2024
4:00 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off (Ad)

Right now, we’re witnessing a monumental shift in the world.

Our No. 1 AI Pick is currently trading for pennies on the dollar compared to Nividia.
10/23/2024
3:09 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2024
11:26 AM
STATE STREET CORP (Filed by)
Viking Therapeutics (Subject)
Form SC 13G/A
09/20/2024
8:20 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
8:21 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
09/20/2024
3:29 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/22/2024
6:23 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
6:23 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:11 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:13 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2024
7:00 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/19/2024
6:47 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/14/2024
7:03 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2024
3:38 PM
SINGLETON J MATTHEW (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/31/2024
3:05 PM
Lian Brian (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:05 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/31/2024
3:05 PM
Viking Therapeutics (Issuer)
ZANTE GREG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/30/2024
4:55 PM
Lian Brian (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
4:56 PM
Mancini Marianna (Reporting)
Viking Therapeutics (Subject)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/30/2024
4:58 PM
Viking Therapeutics (Subject)
ZANTE GREG (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/24/2024
4:00 PM
Viking Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/24/2024
3:10 PM
Viking Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:VKTX) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners